Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
372
days
Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder a retrospective cohort study CYP2D6 genotype and antidepressant response
Authors
Aleksandra Petković Ćurčin; Aleksandra Jeremić; Danilo Joković; Gordana Šupić; Katarina Simić; Filip Milosavljević; Zvezdana Stojanović; Marin M. JukićShow moreShow less
Affiliations
1. Faculty of Medicine, Military Medical Academy, University of Defense, Belgrade, Serbia; 2. Institute for Medical Research, Military Medical Academy, Belgrade, Serbia; 3. Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia; 4. Clinic for Psychiatry, Military Medical Academy, Belgrade, Serbia; 5. Department of Psychiatry, Berkshire Medical Center, Pittsfield, United States of America; 6. Department of Psychiatry and Psychotherapy, School of Medicine, Technische Universität München, München, Germany; 7. Department of Physiology and Pharmacology, Karolinska Institute, Solna, SwedenShow moreShow less
497
days
Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects
Authors
Chris Eijsbouts; Yunxuan Jiang; James R. Ashenhurst; Julie M. Granka; Steven Pitts; Adam Auton; Noura S. Abul-Husn; Alison Chubb; R. Ryanne WuShow moreShow less
Affiliations
1. 23andMe Research Institute, Palo Alto, USAShow moreShow less
77
days
Effects of CYP3A4, CYP3A5 , and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation
Authors
Nahathai Dukaew; Kajohnsak Noppakun; Mingkwan Na Takuathung; Nattharinee Kongta; Ratchanon Inpan; Naruemon Suyayai; Nut KoonrungsesomboonShow moreShow less
Affiliations
1. Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 2. Clinical Research Center for Food and Herbal Product Trials and Development (CR-FAH), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 3. School of Health Science, Mae Fah Luang University, Chiang Rai, Thailand; 4. Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 5. Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 6. Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand; 7. Transplant and Dialysis Unit, Medical Nursing Division, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand; 8. Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandShow moreShow less
123
days
Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study
Authors
Amy Mathieson; Lisa Brunton; Stephanie Gillibrand; Ramona Moldovan; John H. McDermottShow moreShow less
Affiliations
1. Centre for Primary Care and Health Services Research, University of Manchester, Greater Manchester, UK; 2. Division of Evolution & Genomic Sciences, University of Manchester, Greater Manchester, UK; 3. Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, Manchester, Greater Manchester, UK; 4. Department of Psychology, Babeș-Bolyai University, Cluj-Napoca, RomaniaShow moreShow less
119
days
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants
Authors
JM Rodríguez-Piñas; A. Romero-Lorca; A. Novillo; M. Gaibar; M. Rubio; B. Antón-Pascual; S. Hernando; I. Alemany; FI Camacho; M. Cavanagh; M. Boiza; D. Marrupe; AM Martín; R. Khedaoui; A. Fernández-SantanderShow moreShow less
Affiliations
1. Department of Medicine, Faculty of Medicine, Health and Sports. Universidad Europea de Madrid, Madrid, Spain; 2. Human Genetic Variability Group, Hospital La Paz Institute for Health Research–IdiPAZ (La Paz University Hospital–Universidad Autónoma de Madrid–Getafe University Hospital–Universidad Europea de Madrid), Madrid, Spain; 3. Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain; 4. Facultad HM de Ciencias de la Salud, Universidad Camilo José Cela, Instituto de Investigación Sanitaria HMHospitales, Madrid, Spain; 5. Department of Medical Oncology, Hospital Universitario Ramon y Cajal, Madrid, Spain; 6. Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, Madrid, Spain; 7. Department of Pathological Anatomy, Hospital Universitario Fundación Alcorcón, Madrid, Spain; 8. Department of Pathological Anatomy, Hospital Universitario de Getafe, Madrid, Spain; 9. Department of Medical Oncology, Hospital Universitario de Getafe, Madrid, Spain; 10. Department of Pathological Anatomy, Hospital Universitario de Móstoles, Madrid, Spain; 11. Department of Medical Oncology, Hospital Universitario de Móstoles, Madrid, Spain; 12. Department of Medical Oncology, Hospital Universitario de Fuenlabrada, Madrid, Spain; 13. Department of Pathological Anatomy, Hospital Universitario de Fuenlabrada, Madrid, SpainShow moreShow less
296
days
Beyond the ‘Pregnancy Black Box’: a global roadmap for artificial intelligence-driven pharmacogenomics in maternal-neonatal health
Authors
Mohamed A. IsmailShow moreShow less
Affiliations
1. Hamad Medical Corporation, Doha, QatarShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
